Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ignorability and parameter estimation in longitudinal pharmacokinetic studies

E I Ette1, H Sun, T M Ludden

  • 1Vertex Pharmaceuticals, Cambridge, MA 02139, USA.

Journal of Clinical Pharmacology
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for long-lived doubly charged Higgs bosons in pp collisions at sqrt[s] = 1.96 TeV.

Physical review letters·2005
Same author

D(5h) C50X10: saturn-like fullerene derivatives (X=F, Cl, Br).

The Journal of chemical physics·2005
Same author

Gamma-S crystallin gene (CRYGS) mutation causes dominant progressive cortical cataract in humans.

Journal of medical genetics·2005
Same author

Measurement of the W(+)W(-) production cross section in pp collisions at square root[s]=1.96 TeV using dilepton events.

Physical review letters·2005
Same author

Search for anomalous kinematics in tt dilepton events at CDF II.

Physical review letters·2005
Same author

Measurement of the cross section for prompt diphoton production in pp collisions at square root of s=1.96 TeV.

Physical review letters·2005
Same journal

Population Pharmacokinetic Modeling and Simulation to Support the Regulatory Submission of the Two-Injection Start Regimen with Aripiprazole Once-Monthly Long-Acting Injectable Intramuscular Administration in Japanese Patients with Schizophrenia or Bipolar I Disorder.

Journal of clinical pharmacology·2026
Same journal

External Evaluation of Population Pharmacokinetic Models for Factor VIII in Chinese Patients with Hemophilia A.

Journal of clinical pharmacology·2026
Same journal

How to Replace the TQT Study-The Use of Concentration-QTc Modeling to Exclude a Small Effect of a Novel Drug on QT Interval: Historical Perspective and Implementation.

Journal of clinical pharmacology·2026
Same journal

Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.

Journal of clinical pharmacology·2026
Same journal

FDA Gene Therapy Approvals (1998-2025): Current Status, Regulatory Evolution, and Future Directions.

Journal of clinical pharmacology·2026
Same journal

Human Disposition, Metabolism, and Excretion of Sevasemten (EDG-5506), a Selective Modulator of Fast Myosin in Healthy Volunteers.

Journal of clinical pharmacology·2026
See all related articles

Ignoring missing pharmacokinetic data did not impact parameter estimation accuracy. However, increased missingness reduced the precision of parameter estimates in longitudinal pharmacokinetic studies.

Area of Science:

  • Pharmacokinetics
  • Statistical modeling
  • Data analysis

Background:

  • Longitudinal pharmacokinetic data analysis often involves both balanced and unbalanced datasets.
  • Missing data is common, and its impact on parameter estimation is critical.

Purpose of the Study:

  • To investigate the effect of ignoring missing data (ignorability) on parameter estimation accuracy and precision.
  • To evaluate this effect in longitudinal pharmacokinetic studies using a simulation approach.

Main Methods:

  • Simulated a two-compartment pharmacokinetic model with multiple intravenous bolus inputs.
  • Generated datasets with varying proportions (25%-75%) of subjects having missing samples (1-5 per subject).
  • Assessed parameter estimation accuracy and precision across different levels of intersubject variability (15%-60%).

Related Experiment Videos

Main Results:

  • Parameter estimation accuracy remained largely unaffected by the amount of ignorable missing data.
  • The precision of parameter estimates was significantly influenced by the degree of missing data.

Conclusions:

  • Ignorable missing data in longitudinal pharmacokinetic studies does not compromise parameter estimation accuracy.
  • Increased missingness negatively impacts the precision of pharmacokinetic parameter estimates, highlighting the importance of data completeness.